July 2014 Deals & Suits
Novartis AG announced a major asset swap with GlaxoSmithKline plc as well as a agreement to sell its animal health unit to Eli Lilly & Co. on April 22. All told, the deals could be worth more than $30 billion.
This article has been archived, and is no longer available on this website.
Not a LexisAdvance® Subscriber?
LexisAdvance® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisAdvance® customers will be able to access and use ALM's content by subscribing to the LexisAdvance® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Legaltech News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.
ALM's content plays a significant role in your work and research, and now through this alliance LexisAdvance® will bring you access to an even more comprehensive collection of legal content.
For questions call 1-877-256-2472 or contact us at firstname.lastname@example.org